Lupkynis (voclosporin) - Aurinia Pharma
Reply to: "Current Use of PBPK Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis". (PubMed, Clin Pharmacol Ther) - Jun 4, 2025 - No abstract available 
Journal • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
http://www.ncbi.nlm.nih.gov/pubmed/40462353
 
Carolien Versantvoort; Efthymios Manolis; Flora Musuamba Tshinanu; Kevin Blake; Pieter J Colin; Polly Paul
 
Jun 4, 2025
 
Prev Next